Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

516 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development and validation of a cell cycle progression signature for decentralized testing of men with prostate cancer.
Kuhl V, Clegg W, Meek S, Lenz L, Flake DD 2nd, Ronan T, Kornilov M, Horsch D, Scheer M, Farber D, Zalaznick H, Cussenot O, Compérat E, Cancel-Tassin G, Wild PJ, Chun FK, Mandel P, Moinfar F, Cohen T, Delee S, Kronenwett R, Doedt J. Kuhl V, et al. Among authors: cussenot o. Biomark Med. 2022 Apr;16(6):449-459. doi: 10.2217/bmm-2021-0479. Epub 2022 Mar 24. Biomark Med. 2022. PMID: 35321552 Free article.
[Genetic susceptibility to prostate cancer].
Cussenot O, Cancel-Tassin G. Cussenot O, et al. Med Sci (Paris). 2004 May;20(5):562-8. doi: 10.1051/medsci/2004205562. Med Sci (Paris). 2004. PMID: 15190476 Free article. Review. French.
Genetic susceptibility to prostate cancer.
Cancel-Tassin G, Cussenot O. Cancel-Tassin G, et al. Among authors: cussenot o. BJU Int. 2005 Dec;96(9):1380-5. doi: 10.1111/j.1464-410X.2005.05836.x. BJU Int. 2005. PMID: 16287462 Review. No abstract available.
Low penetrance genetic susceptibility to kidney cancer.
Thibault F, Cancel-Tassin G, Cussenot O. Thibault F, et al. Among authors: cussenot o. BJU Int. 2006 Oct;98(4):735-8. doi: 10.1111/j.1464-410X.2006.06351.x. BJU Int. 2006. PMID: 16978268 Review. No abstract available.
Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage.
Rouprêt M, Hupertan V, Yates DR, Catto JW, Rehman I, Meuth M, Ricci S, Lacave R, Cancel-Tassin G, de la Taille A, Rozet F, Cathelineau X, Vallancien G, Hamdy FC, Cussenot O. Rouprêt M, et al. Among authors: cussenot o. Clin Cancer Res. 2007 Mar 15;13(6):1720-5. doi: 10.1158/1078-0432.CCR-06-2467. Clin Cancer Res. 2007. PMID: 17363525
[Impact of obesity on PSA in prostate cancer screening].
Larré S, Azzouzi AR, Cancel-Tassin G, Cormier L, Villette JM, Hoffmann P, Drelon I, Baschet F, Mangin P, Cussenot O. Larré S, et al. Among authors: cussenot o. Prog Urol. 2007 Jun;17(4):815-8. doi: 10.1016/s1166-7087(07)92298-8. Prog Urol. 2007. PMID: 17633992 French.
Phenol sulfotransferase SULT1A1*2 allele and enhanced risk of upper urinary tract urothelial cell carcinoma.
Rouprêt M, Cancel-Tassin G, Comperat E, Fromont G, Sibony M, Molinié V, Allory Y, Triau S, Champigneulle J, Gaffory C, Larré S, de la Taille A, Richard F, Hamdy FC, Cussenot O. Rouprêt M, et al. Among authors: cussenot o. Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2500-3. doi: 10.1158/1055-9965.EPI-07-0361. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 18006944
516 results